Initiation of SGLT2i vs GLP1-RA and incidence of AKI in persons with type 2 diabetes mellitus

被引：0
|
作者：
Jensen, Simon Kok
Heide-Jorgensen, Uffe
Andersen, Ina Trolle
Thomsen, Reimar
Christiansen, Christian Fynbo
机构：
[1] Aarhus Univ Hosp, Dept Clin Epidemiol, Aarhus, Denmark
[2] Aarhus Univ Hosp, Aarhus, Denmark
来源：
NEPHROLOGY DIALYSIS TRANSPLANTATION | 2024年 / 39卷
关键词：
D O I：
10.1093/ndt/gfae069.111
中图分类号：
R3 [基础医学]; R4 [临床医学];
学科分类号：
1001 ; 1002 ; 100602 ;
摘要：
462
引用
收藏
页数：2
相关论文
共 50 条
  • [21] Cardiovascular outcome with SGLT2i and GLP1RA
    Lim, Soo
    Sohn, Minji
    Nauck, Michael A.
    EUROPEAN JOURNAL OF INTERNAL MEDICINE, 2024, 129 : 133 - 136
  • [22] The Difference in the Effects on Microalbuminuria Depending on the Order of GLP-1RA and SGLT2i Therapy in Type 2 Diabetes
    Ohara, Masaya
    Motoyama, Koka
    Tamai, Anna
    Sakura, Takeshi
    Yakushiji, Yosuke
    Hosoi, Masayuki
    DIABETES, 2019, 68
  • [23] SGLT2i and GLP1-RA exert additive cardiorenal protection with a RAS blocker in uninephrectomized db/db mice
    Martos-Guillami, Nerea
    Vergara, Ander
    Llorens-Cebria, Carmen
    Motto, Aku Enam
    Martinez-Diaz, Irene
    Goncalves, Francisco
    Garcias-Ramis, Maria Magdalena
    Allo-Urzainqui, Estibaliz
    Narvaez, Alonso
    Bermejo, Sheila
    Munoz, Vicent
    Leon-Roman, Juan
    Ferrer-Costa, Roser
    Jacobs-Cacha, Conxita
    Vilardell-Vila, Jordi
    Soler, Maria Jose
    FRONTIERS IN PHARMACOLOGY, 2024, 15
  • [24] Trends in GLP1RA and SGLT2i Use in Ischemic Stroke Patients With Diabetes
    Yanus, Matthew R.
    Saleni, Angela
    Bhavsar, Riya
    Zhang, Tony
    McCane, Charles D.
    Pan, Alan P.
    Vahidy, Farhaan
    Gadhia, Rajan R.
    STROKE, 2024, 55
  • [25] The effect of one year treatment with GLP1-RA, SGLT2i and their combination on plasma levels of oxidative and antioxidative biomarkers
    Ikonomidis, I.
    Thymis, J.
    Pavlidis, G.
    Birba, D.
    Kalogeris, A.
    Kousathana, F.
    Kountouri, A.
    Korakas, E.
    Kostelli, G.
    Triantafyllou, C.
    Triantafyllidi, H.
    Andreadou, I.
    Lambadiari, V.
    EUROPEAN HEART JOURNAL, 2021, 42 : 2959 - 2959
  • [26] Combined treatment with SGLT2i and GLP1ra compared with SGLT2i or GLP1ra alone improves survival: a Real-World Registry
    Garcia Vega, D.
    Cinza-Sanjurjo, S.
    Eiras, S.
    Gonzalez-Juanatey, J. R.
    EUROPEAN JOURNAL OF HEART FAILURE, 2024, 26 : 591 - 591
  • [27] Glycaemic control and beta cell function in type 2 diabetes on SGLT2i and GLP-1RA combination therapy
    Martinez, R.
    Al-Jobory, H.
    Adams, J.
    Chavez-Velasquez, A.
    Triplitt, C.
    DeFronzo, R. A.
    Cersosimo, E.
    DIABETOLOGIA, 2017, 60 : S408 - S409
  • [28] Comparative Safety and Effectiveness of GLP-1RA and SGLT2i Use in Adults with Type 2 Diabetes in US Clinical Practice
    Hoffman, Sarah R.
    Lanes, Stephan
    Quimbo, Tracey
    Papazian, Aanahit
    White, Jeff
    Fisher, Vicki
    Cziraky, Mark J.
    Crowley, Matthew J.
    Willey, Vincent
    DIABETES, 2024, 73
  • [29] Patient, provider and formulary characteristics associated with initiation of a SGLT2i or GLP-1RA among medicare beneficiaries with type 2 diabetes: A retrospective cohort study
    Luo, Jing
    Hernandez, Inmaculada
    Gabriel, Joseph
    Gellad, Walid
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2020, 29 : 307 - 308
  • [30] GLP-1RA and SGLT2i: Cardiovascular Impact on Diabetic Patients
    Pablo, Aschner
    Evelyn, Blanc
    Claudia, Folino
    Yanina, Morosan A.
    CURRENT HYPERTENSION REVIEWS, 2021, 17 (02) : 149 - 158
12345